Disclosure Plus

COPUS KOREA Co., Ltd. "Files Lawsuit Seeking Declaration That New Share Issuance Is Invalid"

Shin Ha-yeon
2026-08-18 17:39:32
[E-Daily Reporter Shin Ha-yeon ] COPUS KOREA Co., Ltd.(322780)announced on the 18th that Mr. Shin Yi-cheol filed a lawsuit with the Seoul Western District Court seeking a declaration that the company’s issuance of new shares is invalid.

The plaintiff requested that the issuance of 5,716,461 new common shares—issued by COPUS KOREA Co., Ltd. pursuant to a board resolution on June 26—be declared invalid. The par value of the new shares is 500 won per share, and the issue price is 1,312 won per share, bringing the total issuance amount to approximately 7.5 billion won.

The company stated, “We plan to appoint legal counsel and respond in accordance with legal procedures to this lawsuit, which is based on claims that do not align with the facts.”

Economy

Corporation

IT·Science

Economy

[Noul Co., Ltd. Deep Seek ④] The Aftermath of an RP Agreement Made During a Rights Offering… 4 Million Shares Held by the Largest Shareholder Transferred to External Parties

MSEED, the largest shareholder of artificial intelligence (AI) diagnostics company Noul Co., Ltd.(376930), is facing repercussions from a repurchase agreement (RP) signed during its participation in a…
2026-09-13 08:06:02

Corporation

"Now Is the Time for Chuseok Shopping": From Ribs to Cosmetics… Discounts Are Everywhere

The retail and e-commerce sectors are stepping up efforts to attract customers ahead of the Chuseok holiday. Department stores and outlet malls are hosting character-themed and fashion pop-up shops as…
2026-09-12 09:22:11

IT·Science

First Domestically Developed New Drug for Dry Eye Syndrome Launched… Labor-Management Tensions Resurface at Samsung Bio [Weekly Bio Roundup]

(Photo: ChatGPT) During the second week of September (Sept. 7–11), the domestic pharmaceutical and biotech industry saw “Latica Eye Drops,” a dry eye treatment jointly developed by GL Pharm Tech C…
2026-09-13 08:31:01